Press Release

  View printer-friendly version

« Back

Collegium to Present at the Jefferies 2015 Global Healthcare Conference

May 27, 2015 at 7:13 AM EDT

CANTON, Mass., May 27, 2015 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasdaq:COLL) announced today that the Company's Chairman and CEO, Michael Heffernan, will present at the Jefferies 2015 Healthcare Conference in New York City. The presentation is scheduled for Monday, June 1, 2015 at 1:30pm Eastern Time.

About Collegium Pharmaceutical, Inc.

Collegium is a specialty pharmaceutical company focused on developing a portfolio of products that incorporate its patent-protected DETERx technology platform for the treatment of chronic pain. The DETERx oral drug delivery technology is designed to provide extended-release delivery, unique abuse-deterrent properties, and flexible dose administration options.

CONTACT: Investor Contact:
         Doug Carlson
         Vice President, Corporate Development

Collegium Pharmaceutical Logo

Collegium Pharmaceutical